Partner
盛希泰
洪泰基金创始合伙人、董事长、华泰联合证券首任董事长, Hongtai Fund
- Firm
- Hongtai Fund
- Title
- 洪泰基金创始合伙人、董事长、华泰联合证券首任董事长
- Role
- Employee
Record updated 17 September 2026
About
Mr. Sheng Xitai is an important participant in the early Chinese capital market. In a 20-year investment banking career he gained IPO experience with more than a hundred companies and built a top M&A team in China's capital market. Since moving into investing, he has invested in many unicorn and quasi-unicorn companies, including Kunyuan Biotech, Zhongshang Huimin, Kunlunjue, Deep Blue, Xiaoxian Dun, Yidianyun (2416.HK), KK Group, Linuo Special Glass (301188.SZ), Hanyi Fonts (301270.SZ), Guoxing Yuhang, Yunsheng Intelligence, Hoth Pharma (688302.SH), Moore Threads, Quanxin Biotech (2509.HK), Orbbec (688322.SH), COSMOPlat, UISEE, Guoqing Hydrogen Technology, Ningxia Hanyao, Hozon New Energy (Neta Auto), Huasheng New Energy, Orienspace and others.
Is this you? Remove my profile